T1	SectionAnnotate 83 87	HPI:
T2	SectionSkip 2620 4758	Current Outpatient Prescriptions   Medication Sig Dispense Refill    acetaminophen (TYLENOL) 325 mg tablet Take 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for Pain. Dose, strength, route or frequency not available. 180 tablet 3    alendronate (FOSAMAX) 70 mg tablet TAKE 1 TABLET BY MOUTH EVERY 7 DAYS 12 tablet 3    ascorbate calcium (VITAMIN C ORAL) Take by mouth.      baclofen (LIORESAL) 10 mg tablet Take 1 tablet (10 mg total) by mouth nightly as needed (Muscle pain, use at night only). 90 tablet 3    benzonatate (TESSALON) 100 mg capsule Take 1 capsule (100 mg total) by mouth 3 (three) times daily as needed for Cough. 90 capsule 3    clotrimazole (LOTRIMIN) 1 % cream APPLY EXTERNALLY TO THE AFFECTED AREA TWICE DAILY 60 g 0    cyanocobalamin, vitamin B-12, (VITAMIN B-12 ORAL) Take by mouth.      dextran 70-hypromellose (NATURAL BALANCE TEARS) 0.1-0.3 % DROPSOLN ophthalmic solution Place 2 drops into both eyes 2 (two) times daily. 30 mL 3    ergocalciferol, vitamin D2, (VITAMIN D ORAL) Take by mouth.      loratadine (CLARITIN) 10 mg tablet Take 1 tablet (10 mg total) by mouth Daily. 90 tablet 3    melatonin 3 mg TAB tablet Take 1 tablet (3 mg total) by mouth nightly at bedtime. 90 tablet 3    mometasone (NASONEX) 50 mcg/actuation spray 2 
 sprays by Nasal route Daily. 17 g 1    multivitamin tablet Take 1 tablet by mouth Daily.        omeprazole (PRILOSEC) 20 mg capsule TAKE 1 CAPSULE BY MOUTH DAILY 90 capsule 1    promethazine-dextromethorphan 6.25-15 mg/5 mL syrup Take 5 mLs by mouth 4 (four) times daily as needed for Cough. 473 mL 3    blood pressure monitor KIT Please check your blood pressure daily and record (Patient not taking: Reported on 01/24/2018) 1 kit 0    menthol (BENGAY COLD THERAPY) 5 % GEL Apply 1 Application topically 2 (two) times daily. (Patient not taking: Reported on 01/24/2018) 85 g prn    VENTOLIN HFA 90 mcg/actuation metered dose inhaler INHALE 1 PUFF INTO THE LUNGS EVERY 4 HOURS AS NEEDED FOR WHEEZING OR SHORTNESS OF BREATH (Patient not taking: Reported on 10/24/2017) 54 g 0     No current facility-administered medications for this visit.
T3	SectionAnnotate 5347 5361	SOCIAL HISTORY
T4	SectionAnnotate 6572 6586	Social History
T7	SectionAnnotate 13660 13677	ASSESSMENT & PLAN
T8	PROBLEM 39 79	HER2 negative cancer of the right breast
T9	PROBLEM 134 149	R breast cancer
T10	TEST 211 231	Bilateral Breast MRI
T11	PROBLEM 241 296	1.2 x 0.7 x 0.7 cm mass in the upper outer right breast
T12	PROBLEM 299 309	A 2nd mass
T13	PROBLEM 343 357	the index mass
T14	PROBLEM 388 403	A 3rd 9 mm mass
T15	PROBLEM 443 458	the larger mass
T16	TEST 473 492	R Breast Ultrasound
T17	PROBLEM 529 554	a 0.7 x 0.9 x 0.9 cm mass
T18	PROBLEM 556 562	A mass
T19	TEST 656 674	Core needle biopsy
T20	PROBLEM 678 683	1mass
T21	TEST 724 729	grade
T22	TEST 732 734	ER
T23	TEST 738 740	PR
T24	TEST 750 754	Her2
T25	TEST 758 761	IHC
T26	TEST 776 779	IDC
T27	TEST 785 791	a Ki67
T28	TEST 802 808	Biopsy
T29	PROBLEM 812 820	the mass
T30	TEST 865 868	IDC
T31	TEST 898 900	PR
T32	TEST 904 913	Her2 0IHC
T33	TEST 914 918	FISH
T34	TEST 933 939	a Ki67
T35	TEST 1065 1113	CT Limited Whole Body- right lateral breast mass
T36	DiseaseState 1152 1169	recurrent disease
T37	Metastasis 1186 1219	hypermetabolic metastatic disease
T38	PROBLEM 1257 1262	fever
T39	Symptom 1264 1270	chills
T40	Symptom 1272 1283	diaphoresis
T41	Symptom 1285 1300	appetite change
T42	Symptom 1302 1309	fatigue
T43	Symptom 1314 1338	unexpected weight change
T44	Symptom 1343 1360	chronic headaches
T45	Symptom 1381 1393	hearing loss
T46	Symptom 1395 1405	nosebleeds
T47	PROBLEM 1407 1417	congestion
T48	Symptom 1419 1430	sore throat
T49	Symptom 1432 1443	mouth sores
T50	Symptom 1445 1454	neck pain
T51	Symptom 1456 1470	sinus pressure
T52	Symptom 1475 1483	tinnitus
T53	Symptom 1507 1518	photophobia
T54	Symptom 1520 1524	pain
T55	Symptom 1526 1535	discharge
T56	Symptom 1537 1544	redness
T57	Symptom 1546 1553	itching
T58	Symptom 1558 1576	visual disturbance
T59	Symptom 1606 1611	apnea
T60	Symptom 1613 1628	chest tightness
T61	Symptom 1630 1649	shortness of breath
T62	Symptom 1651 1659	wheezing
T63	PROBLEM 1663 1677	allergic cough
T64	Symptom 1708 1718	chest pain
T65	Symptom 1720 1732	palpitations
T66	Symptom 1737 1749	leg swelling
T67	Symptom 1784 1790	nausea
T68	Symptom 1792 1800	vomiting
T69	Symptom 1802 1816	abdominal pain
T70	Symptom 1818 1826	diarrhea
T71	Symptom 1828 1840	constipation
T72	Symptom 1842 1856	blood in stool
T73	Symptom 1861 1881	abdominal distention
T74	Symptom 1913 1920	dysuria
T75	Symptom 1922 1929	urgency
T76	Symptom 1931 1940	frequency
T77	Symptom 1942 1951	hematuria
T78	PROBLEM 1953 1971	vaginal 
 bleeding
T79	PROBLEM 1975 1984	discharge
T80	Symptom 1988 2008	difficulty urinating
T81	Symptom 2042 2050	myalgias
T82	Symptom 2053 2067	joint swelling
T83	Symptom 2072 2083	arthralgias
T84	PROBLEM 2087 2117	chronic back and shoulder pain
T85	Symptom 2149 2156	itching
T86	Symptom 2158 2162	rash
T87	Symptom 2174 2199	tenderness at biopsy site
T88	Symptom 2246 2256	neuropathy
T89	Symptom 2258 2267	dizziness
T90	Symptom 2269 2276	tremors
T91	Symptom 2278 2286	seizures
T92	Symptom 2288 2295	syncope
T93	Symptom 2297 2314	speech difficulty
T94	Symptom 2316 2324	weakness
T95	Symptom 2326 2342	light-headedness
T96	Symptom 2344 2352	numbness
T97	Symptom 2357 2366	headaches
T98	Symptom 2398 2408	adenopathy
T99	Symptom 2419 2431	bruise/bleed
T100	Symptom 2479 2493	suicidal ideas
T101	Symptom 2495 2512	sleep disturbance
T102	Symptom 2514 2537	decreased concentration
T103	Symptom 2541 2548	anxiety
T104	PROBLEM 2553 2560	disease
T105	PROBLEM 2579 2602	treatment complications
T106	TREATMENT 2607 2618	MEDICATIONS
T107	TREATMENT 2620 2665	Current Outpatient Prescriptions   Medication
T108	TREATMENT 2690 2713	acetaminophen (TYLENOL)
T109	PROBLEM 2800 2804	Pain
T110	TREATMENT 2873 2894	alendronate (FOSAMAX)
T111	TREATMENT 2960 2994	ascorbate calcium (VITAMIN C ORAL)
T112	TREATMENT 3016 3035	baclofen (LIORESAL)
T113	PROBLEM 3105 3116	Muscle pain
T114	TREATMENT 3154 3176	benzonatate (TESSALON)
T115	PROBLEM 3267 3272	Cough
T116	TREATMENT 3291 3314	clotrimazole (LOTRIMIN)
T117	TREATMENT 3345 3362	THE AFFECTED AREA
T118	TREATMENT 3386 3400	cyanocobalamin
T119	TREATMENT 3402 3435	vitamin B-12, (VITAMIN B-12 ORAL)
T120	TREATMENT 3457 3464	dextran
T121	TREATMENT 3468 3504	hypromellose (NATURAL BALANCE TEARS)
T122	TREATMENT 3606 3620	ergocalciferol
T123	TREATMENT 3622 3650	vitamin D2, (VITAMIN D ORAL)
T124	TREATMENT 3672 3693	loratadine (CLARITIN)
T125	TREATMENT 3767 3776	melatonin
T126	TREATMENT 3865 3885	mometasone (NASONEX)
T127	TREATMENT 3953 3965	multivitamin
T128	TREATMENT 4011 4032	omeprazole (PRILOSEC)
T129	TREATMENT 4094 4123	promethazine-dextromethorphan
T130	PROBLEM 4201 4206	Cough
T131	TEST 4221 4235	blood pressure
T132	TEST 4261 4280	your blood pressure
T133	TREATMENT 4355 4383	menthol (BENGAY COLD THERAPY
T134	TREATMENT 4502 4514	VENTOLIN HFA
T135	TREATMENT 4521 4552	/actuation metered dose inhaler
T136	PROBLEM 4610 4618	WHEEZING
T137	PROBLEM 4622 4641	SHORTNESS OF BREATH
T138	TREATMENT 4731 4742	medications
T139	PROBLEM 4768 4788	ALLERGIES  Allergies
T140	TREATMENT 4809 4827	Allergen Reactions
T141	TREATMENT 4832 4850	Iodinated Contrast
T142	TREATMENT 4861 4875	Iv Dye Itching
T143	PROBLEM 4880 4884	Rash
T144	TEST 4921 4929	CT Scans
T145	TEST 4974 4986	future scans
T146	TREATMENT 4991 5037	Contrast [Gadolinium-Containing Contrast Media
T147	PROBLEM 5039 5046	Itching
T148	PROBLEM 5078 5086	allergic
T149	PROBLEM 5090 5093	GAD
T150	PROBLEM 5130 5138	allergic
T151	TREATMENT 5187 5191	meds
T152	TREATMENT 5207 5232	Hydrocodone-Acetaminophen
T153	PROBLEM 5233 5239	Nausea
T154	TREATMENT 5249 5260	Penicillins
T155	PROBLEM 5294 5304	Runny nose
T156	PROBLEM 5309 5318	dizziness
T157	ClinicalCondition 5406 5414	Cataract
T158	PROBLEM 5420 5435	Elevated CA-125
T159	PROBLEM 5441 5479	GERD (gastroesophageal reflux disease)
T160	PROBLEM 5485 5498	Kidney stones
T161	PROBLEM 5504 5548	Metastatic papillary carcinoma to lymph node
T162	PROBLEM 5563 5586	left pelvic lymph nodes
T163	PROBLEM 5591 5595	NSVD
T164	TREATMENT 5604 5632	spontaneous vaginal delivery
T165	ClinicalCondition 5645 5659	Ovarian cancer
T166	PROBLEM 5679 5689	stage IIIC
T167	PROBLEM 5696 5722	platinum-sensitive disease
T168	PROBLEM 5770 5786	Onset    Cancer
T169	PROBLEM 5801 5814	breast cancer
T170	PROBLEM 5819 5831	Hypertension
T171	PROBLEM 5844 5850	Stroke
T172	PROBLEM 5867 5875	Diabetes
T173	PROBLEM 5876 5893	Other     Cancer
T174	PROBLEM 5894 5918	Sister      liver cancer
T175	PROBLEM 5923 5931	Diabetes
T176	PROBLEM 5945 5957	Hypertension
T177	PROBLEM 5971 5979	Glaucoma
T178	PROBLEM 5993 6005	Hypertension
T179	PROBLEM 6018 6026	Diabetes
T180	PROBLEM 6039 6047	Glaucoma
T181	PROBLEM 6081 6094	Breast cancer
T182	TREATMENT 6096 6116	bilateral mastectomy
T183	PROBLEM 6121 6130	Amblyopia
T184	PROBLEM 6143 6152	Blindness
T185	PROBLEM 6165 6174	Cataracts
T186	PROBLEM 6187 6198	Keratoconus
T187	PROBLEM 6211 6224	Macular degen
T188	PROBLEM 6237 6255	Retinal detachment
T189	PROBLEM 6268 6278	Strabismus
T190	PROBLEM 6291 6306	Anesth problems
T191	ClinicalCondition 6319 6336	Bleeding disorder
T192	ClinicalCondition 6349 6368	Anesthesia problems
T193	ClinicalCondition 6381 6399	Autoimmune disease
T194	ClinicalCondition 6412 6432	Congenital Anomalies
T195	ClinicalCondition 6445 6460	Hyperthyroidism
T196	ClinicalCondition 6473 6487	Hypothyroidism
T197	ClinicalCondition 6500 6508	Melanoma
T198	ClinicalCondition 6521 6538	Neurofibromatosis
T199	ClinicalCondition 6551 6557	Ptosis
T200	TEST 7116 7120	ECOG
T201	TEST 7124 7135	Vital Signs
T202	TEST 7138 7140	BP
T203	TEST 7151 7156	Pulse
T204	TEST 7163 7167	Temp
T205	TEST 7173 7174	C
T206	TEST 7194 7198	Resp
T207	TEST 7205 7207	Ht
T208	TEST 7256 7258	Wt
T209	TEST 7286 7289	LMP
T210	TEST 7304 7308	SpO2
T211	PROBLEM 7379 7382	NAD
T212	PROBLEM 7407 7413	rashes
T213	PROBLEM 7417 7424	lesions
T214	PROBLEM 7440 7449	anicteric
T215	PROBLEM 7472 7489	sinuses nontender
T216	PROBLEM 7528 7536	erythema
T217	PROBLEM 7541 7547	thrush
T218	PROBLEM 7567 7621	cervical, supraclavicular, or axillary lymphadenopathy
T219	TEST 7665 7675	percussion
T220	PROBLEM 7680 7687	wheezes
T221	PROBLEM 7689 7696	rhonchi
T222	PROBLEM 7701 7709	crackles
T223	PROBLEM 7764 7771	murmurs
T224	PROBLEM 7776 7781	edema
T225	PROBLEM 7792 7814	firm palpable 
 nodule
T226	PROBLEM 7906 7915	nontender
T227	PROBLEM 7920 7930	distention
T228	PROBLEM 7935 7947	organomegaly
T229	PROBLEM 7970 8007	point tenderness over bones or joints
T230	PROBLEM 8047 8078	focal motor or sensory deficits
T231	PROBLEM 8388 8409	BRCA1 genetic carrier
T232	PROBLEM 8428 8442	ovarian cancer
T233	PROBLEM 8447 8479	triple negative right breast IDC
T234	PROBLEM 8485 8495	new masses
T235	TEST 8499 8508	mammogram
T236	PROBLEM 8551 8581	hypermetabolic lymphadenopathy
T237	PROBLEM 8594 8604	metastases
T238	PROBLEM 8639 8649	metastases
T239	PROBLEM 8662 8672	metastases
T240	PROBLEM 8682 8748	Right lateral breast dumbbell shaped enhancing hypermetabolic mass
T241	TEST 8772 8779	SUV Max
T242	PROBLEM 8860 8881	symmetric, FDG uptake
T243	PROBLEM 8965 8976	mass effect
T244	TEST 8985 8997	these images
T245	TEST 9027 9030	MRI
T246	PROBLEM 9058 9099	intracranial and/or skull base metastases
T247	PROBLEM 9168 9213	Unchanged right upper lobe pleural-based mass
T248	PROBLEM 9276 9299	significant FDG avidity
T249	PROBLEM 9301 9354	Unchanged left upper and lower lobe pulmonary nodules
T250	TEST 9410 9415	image
T251	PROBLEM 9498 9534	Scattered bone islands in the pelvis
T252	PROBLEM 9573 9637	Multilevel degenerative changes of the cervical and lumbar spine
T253	PROBLEM 9639 9673	Unchanged 3.4 cm lipomatous lesion
T254	TREATMENT 9707 9732	Midline abdominal staples
T255	PROBLEM 9753 9805	Hypermetabolic  (FDG avid) right lateral breast mass
T256	PROBLEM 9844 9861	recurrent disease
T257	PROBLEM 9878 9911	hypermetabolic metastatic disease
T258	TEST 9917 9952	Right breast diagnostic mammography
T259	TEST 9954 9973	Limited R breast US
T260	TEST 9999 10017	Prior examinations
T261	TEST 10060 10063	MRI
T262	PROBLEM 10166 10188	fibroglandular density
T263	TEST 10191 10200	BB marker
T264	PROBLEM 10252 10265	palpated lump
T265	PROBLEM 10281 10291	two masses
T266	TEST 10293 10304	both biopsy
T267	TREATMENT 10312 10343	IDC (ribbon clip and heart clip
T268	PROBLEM 10346 10364	The irregular mass
T269	TREATMENT 10376 10391	the ribbon clip
T270	PROBLEM 10448 10480	the more posterior obscured mass
T271	TEST 10492 10506	the heart clip
T272	TEST 10559 10568	BB marker
T273	PROBLEM 10643 10656	palpated lump
T274	TEST 10705 10715	Ultrasound
T275	PROBLEM 10739 10762	sonographic abnormality
T276	PROBLEM 10789 10802	palpated lump
T277	TEST 10900 10938	Limited ultrasound of the right axilla
T278	PROBLEM 10952 10963	lymph nodes
T279	PROBLEM 11042 11072	Known biopsy proven malignancy
T280	TEST 11074 11081	BI-RADS
T281	TREATMENT 11120 11159	continued surgical/oncologic management
T282	TEST 11163 11178	two-site biopsy
T283	PROBLEM 11186 11209	right breast malignancy
T284	TEST 11280 11299	today's examination
T285	PROBLEM 11348 11361	palpated lump
T286	TEST 11488 11508	palpation-guided FNA
T287	TEST 11530 11554	Bilateral MRI of Breasts
T288	TEST 11580 11598	Prior examinations
T289	TEST 11617 11626	mammogram
T290	TEST 11686 11689	MRI
T291	TEST 11703 11733	This bilateral breast MRI exam
T292	PROBLEM 11747 11777	minimum background enhancement
T293	PROBLEM 11809 11830	fibroglandular tissue
T294	PROBLEM 11859 11917	a new 12 x 7 x 7 mm (ML x AP x CC) irregularly shaped mass
T295	PROBLEM 11923 11941	spiculated margins
T296	TEST 11991 12018	Signal intensity/time curve
T297	PROBLEM 12032 12083	rapid initial rise and washout enhancement kinetics
T298	PROBLEM 12086 12097	This lesion
T299	TEST 12114 12138	axial postcontrast image
T300	PROBLEM 12237 12301	a second new 6 x 6 x 7 mm (ML x AP x CC) irregularly shaped mass
T301	PROBLEM 12307 12324	irregular margins
T302	TEST 12326 12353	Signal intensity/time curve
T303	PROBLEM 12367 12418	rapid initial rise and washout enhancement kinetics
T304	PROBLEM 12421 12432	This lesion
T305	PROBLEM 12541 12561	non-mass enhancement
T306	PROBLEM 12567 12650	linear distribution and clumped internal enhancement in the lower outer left breast
T307	TEST 12693 12696	MRI
T308	PROBLEM 12760 12793	new abnormal areas of enhancement
T309	PROBLEM 12819 12829	malignancy
T310	TEST 12889 12896	BI-RADS
T311	PROBLEM 12959 12983	Two new irregular masses
T312	PROBLEM 12998 13015	rapid enhancement
T313	TREATMENT 13021 13028	washout
T314	TEST 13098 13131	diagnostic right breast mammogram
T315	TEST 13137 13156	targeted ultrasound
T316	TEST 13161 13179	further evaluation
T317	TEST 13184 13199	biopsy planning
T318	TEST 13215 13255	stereotactic or ultrasound-guided biopsy
T319	TEST 13300 13309	mammogram
T320	TEST 13313 13323	ultrasound
T321	TEST 13340 13361	MR-guided core biopsy
T322	PROBLEM 13369 13413	Significant interval decrease in conspicuity
T323	PROBLEM 13450 13470	non-mass enhancement
T324	PROBLEM 13535 13552	a benign etiology
T325	TEST 13554 13572	Annual mammography
T326	TEST 13588 13591	MRI
T327	TEST 13632 13651	high-risk screening
T328	PROBLEM 13722 13737	R breast cancer
T329	ClinicalCondition 13789 13802	Breast Cancer
T330	TEST 13806 13818	Latest PETCT
T331	PROBLEM 13842 13857	R breast lesion
T332	TREATMENT 13922 13927	chemo
T333	TREATMENT 14007 14033	Port placement ASAP  Chemo
T334	TREATMENT 14049 14054	taxol
T335	TREATMENT 14078 14083	chemo
T336	TREATMENT 14275 14286	medications
T337	TREATMENT 14447 14465	the treatment plan
T338	PROBLEM 14467 14475	symptoms
T339	TREATMENT 14480 14499	therapeutic options
T340	BiomarkerName 31 33	HR
A1	HistoryVal T340 new
A2	EpisodeDescription T340 FirstOccurrence
T341	BiomarkerResult 34 37	low
A3	BiomarkerResultVal T341 LowPositive
*	BiomarkerRel T341 T340
T342	BiomarkerName 39 43	HER2
T343	BiomarkerResult 44 52	negative
A4	BiomarkerResultVal T343 Negative
*	BiomarkerRel T342 T343
T344	TumorCharacteristics 143 149	cancer
T345	Site 136 142	breast
R1	SiteOf Arg1:T345 Arg2:T344	
T346	Laterality 134 135	R
R2	LateralityOfSite Arg1:T346 Arg2:T345	
T347	Datetime 199 209	10/04/2017
T348	Radiology 228 231	MRI
A5	IntentVal T348 others
T349	Site 221 227	Breast
T350	Laterality 211 220	Bilateral
R3	LateralityOfSite Arg1:T350 Arg2:T349	
R4	SiteOf Arg1:T349 Arg2:T348	
T351	Size 241 259	1.2 x 0.7 x 0.7 cm
A6	EpisodeDescription T351 FirstOccurrence
T352	RadPathResult 260 264	mass
A7	RadPathResultVal T352 InitialCancerDiagnosis
T353	Site 290 296	breast
T354	Site 272 283	upper outer
T355	Laterality 284 289	right
R5	LateralityOfSite Arg1:T355 Arg2:T353	
R6	LateralityOfSite Arg1:T355 Arg2:T354	
R7	SiteOf Arg1:T354 Arg2:T352	
R8	ResultOfTest Desc:T352 Test:T348	
R9	TestOrProcedureReveals Test:T348 Desc:T351	
T356	RadPathResult 305 309	mass
A8	RadPathResultVal T356 InitialCancerDiagnosis
T357	Site 318 339	posterior and lateral
R10	SiteOf Arg1:T357 Arg2:T356	
T358	Size 368 386	0.6 x 0.6 x 0.7 cm
A9	EpisodeDescription T358 FirstOccurrence
R11	SiteOf Arg1:T357 Arg2:T358	
R12	SiteOf Arg1:T357 Arg2:T348	
T359	Size 394 398	9 mm
T360	RadPathResult 399 403	mass
A10	RadPathResultVal T360 InitialCancerDiagnosis
T361	Site 417 439	posterior and superior
A11	EpisodeDescription T359 FirstOccurrence
T362	Datetime 642 652	10/11/2017
T363	ProcedureName 656 674	Core needle biopsy
A12	IntentVal T363 diagnosis
T364	Site 687 714	10o'clock 10 cm from nipple
R15	SiteOf Arg1:T364 Arg2:T363	
T365	Size 717 723	0.6 cm
A13	EpisodeDescription T365 FirstOccurrence
T366	Grade 730 731	3
A14	EpisodeDescription T366 FirstOccurrence
T367	BiomarkerName 732 734	ER
A15	EpisodeDescription T367 FirstOccurrence
T368	BiomarkerResult 735 737	1%
A16	BiomarkerResultVal T368 LowPositive
*	BiomarkerRel T367 T368
R16	TestOrProcedureReveals Test:T363 Desc:T365	
R17	TestOrProcedureReveals Test:T363 Desc:T366	
R18	TestOrProcedureReveals Test:T363 Desc:T367	
T369	BiomarkerName 738 740	PR
T370	BiomarkerResult 741 749	negative
A17	BiomarkerResultVal T370 Negative
*	BiomarkerRel T370 T369
T371	BiomarkerName 750 754	Her2
T372	BiomarkerResult 755 757	1+
A18	BiomarkerResultVal T372 Negative
T373	Pathology 758 766	IHC/FISH
A19	IntentVal T373 diagnosis
T374	RadPathResult 767 775	negative
A20	RadPathResultVal T374 Others
R19	ResultOfTest Desc:T374 Test:T373	
T375	Histology 776 779	IDC
A21	EpisodeDescription T375 FirstOccurrence
T376	Pathology 787 791	Ki67
A22	IntentVal T376 diagnosis
T377	RadPathResult 795 798	70%
A23	RadPathResultVal T377 Others
R20	ResultOfTest Desc:T377 Test:T376	
T378	Datetime 1049 1059	01/10/2018
T379	Radiology 1061 1075	PET CT Limited
A24	IntentVal T379 staging
T380	RadPathResult 1109 1113	mass
A25	EpisodeDescription T380 Recurrence
T381	Site 1094 1108	lateral breast
T382	Laterality 1088 1093	right
R21	LateralityOfSite Arg1:T382 Arg2:T381	
R22	SiteOf Arg1:T381 Arg2:T380	
T383	Size 1123 1135	2.7 x 1.7 cm
A26	EpisodeDescription T383 Recurrence
R23	TestOrProcedureReveals Test:T379 Desc:T36	
R24	TestOrProcedureReveals Test:T379 Desc:T380	
T384	Symptom 1663 1677	allergic cough
A27	NegationModalityVal T384 affirmed
A28	IsPresentOnFirstCancerDiagnosis T384 yes
A29	IsCausedByDiagnosedCancer T384 no
A30	ChronicVal T384 chronic
A31	ContinuityVal T384 stable
T385	Symptom 2113 2117	pain
A32	NegationModalityVal T385 affirmed
A33	IsPresentOnFirstCancerDiagnosis T385 yes
A34	IsCausedByDiagnosedCancer T385 no
A35	ChronicVal T385 chronic
T386	Site 2104 2112	shoulder
T387	Site 2095 2099	back
R25	SiteOf Arg1:T387 Arg2:T385	
R26	SiteOf Arg1:T386 Arg2:T385	
T388	Duration 2120 2127	2 years
A37	ChronicVal T165 non-chronic
A38	ContinuityVal T165 stable
A39	ExperiencerVal T165 patient
T389	Stage 5685 5689	IIIC
A40	NegationModalityVal T165 affirmed
A41	HistoryVal T165 history
A42	EpisodeDescription T165 Recurrence
T390	Datetime 5660 5664	1998
T391	DiseaseState 5668 5677	recurrent
T392	TreatmentType 13922 13927	chemo
A43	NegationModalityVal T392 hypothetical_in_future
A44	TreatmentTypeVal T392 others
T393	ProcedureName 14007 14021	Port placement
A45	NegationModalityVal T393 affirmed
A46	IntentVal T393 treatment-others
A47	TreatmentTypeVal T393 others
T394	MedicationName 14049 14054	taxol
A48	NegationModalityVal T394 hypothetical_in_future
A50	TreatmentIntentVal T394 palliative
A51	TreatmentCategory T394 AntiNeoPlastics
T395	Cycles 14057 14059	12
T397	Datetime 14096 14110	next Wednesday
T398	Datetime 953 963	10/19/2017
T399	Datetime 1000 1010	12/27/2017
T400	ProcedureName 802 808	Biopsy
A53	IntentVal T400 diagnosis
T401	SectionSkip 4768 5318	ALLERGIES  Allergies/Contraindications   Allergen Reactions    Iodinated Contrast- Oral And Iv Dye Itching and Rash     Patient takes pre-meds prior to CT Scans. She will continue to need the pre-meds for future scans    Contrast [Gadolinium-Containing Contrast Media] Itching     Patient not sure if she is allergic to GAD.   Will add to allergy list: She is allergic to NON-Ionic Contrast (CT,etc.) She takes pre - meds for this.     Hydrocodone-Acetaminophen Nausea Only    Penicillins Unknown    Pollen Extracts      Runny nose and dizziness
A54	SectionSkipType T401 allergies
T5	SectionSkip 7101 7805;7808 8174	PHYSICAL EXAM  ECOG 0  Vital Signs:  BP 127/66  | Pulse 69  | Temp 36.3 C (97.4 F) (Oral)  | Resp 16  | Ht 158 cm (5' 2.21") Comment: 01/24/2018 @ ***** | Wt 59.1 kg (130 lb 6.4 oz)  | LMP 01/09/1998  | SpO2 98%  | Breastfeeding? No  | BMI 23.69 kg/m     Constitutional:  WDWN, NAD.  Skin: warm, moist. No rashes or lesions.  Eyes: sclera anicteric, PERRL, EOMI.   HENT: sinuses nontender, nasal mucosa intact, pharynx without erythema, no thrush.   Lymph Nodes: no cervical, supraclavicular, or axillary lymphadenopathy.    Respiratory: BL lungs CTA, resonant to percussion, no wheezes, rhonchi, or crackles  Cardiovascular: normal heart rate, normal rhythm, no murmurs, no edema  Breast:: firm palpable nodule felt at 11 o'clock between axilla and areola in R breast.   GI: bowel sounds normal, soft, nontender, no distention, no organomegaly   Musculoskeletal: no point tenderness over bones or joints   Neurologic: alert & oriented x 3, no focal motor or sensory deficits  Psychiatric: mood stable    RESULTS  I have personally reviewed and interpreted the following:
A55	SectionSkipType T5 physical_exam
T6	SectionSkip 2607 3910;3913 4758	MEDICATIONS  Current Outpatient Prescriptions   Medication Sig Dispense Refill    acetaminophen (TYLENOL) 325 mg tablet Take 1 tablet (325 mg total) by mouth every 6 (six) hours as needed for Pain. Dose, strength, route or frequency not available. 180 tablet 3    alendronate (FOSAMAX) 70 mg tablet TAKE 1 TABLET BY MOUTH EVERY 7 DAYS 12 tablet 3    ascorbate calcium (VITAMIN C ORAL) Take by mouth.      baclofen (LIORESAL) 10 mg tablet Take 1 tablet (10 mg total) by mouth nightly as needed (Muscle pain, use at night only). 90 tablet 3    benzonatate (TESSALON) 100 mg capsule Take 1 capsule (100 mg total) by mouth 3 (three) times daily as needed for Cough. 90 capsule 3    clotrimazole (LOTRIMIN) 1 % cream APPLY EXTERNALLY TO THE AFFECTED AREA TWICE DAILY 60 g 0    cyanocobalamin, vitamin B-12, (VITAMIN B-12 ORAL) Take by mouth.      dextran 70-hypromellose (NATURAL BALANCE TEARS) 0.1-0.3 % DROPSOLN ophthalmic solution Place 2 drops into both eyes 2 (two) times daily. 30 mL 3    ergocalciferol, vitamin D2, (VITAMIN D ORAL) Take by mouth.      loratadine (CLARITIN) 10 mg tablet Take 1 tablet (10 mg total) by mouth Daily. 90 tablet 3    melatonin 3 mg TAB tablet Take 1 tablet (3 mg total) by mouth nightly at bedtime. 90 tablet 3    mometasone (NASONEX) 50 mcg/actuation spray 2 sprays by Nasal route Daily. 17 g 1    multivitamin tablet Take 1 tablet by mouth Daily.        omeprazole (PRILOSEC) 20 mg capsule TAKE 1 CAPSULE BY MOUTH DAILY 90 capsule 1    promethazine-dextromethorphan 6.25-15 mg/5 mL syrup Take 5 mLs by mouth 4 (four) times daily as needed for Cough. 473 mL 3    blood pressure monitor KIT Please check your blood pressure daily and record (Patient not taking: Reported on 01/24/2018) 1 kit 0    menthol (BENGAY COLD THERAPY) 5 % GEL Apply 1 Application topically 2 (two) times daily. (Patient not taking: Reported on 01/24/2018) 85 g prn    VENTOLIN HFA 90 mcg/actuation metered dose inhaler INHALE 1 PUFF INTO THE LUNGS EVERY 4 HOURS AS NEEDED FOR WHEEZING OR SHORTNESS OF BREATH (Patient not taking: Reported on 10/24/2017) 54 g 0     No current facility-administered medications for this visit.
A57	SectionSkipType T6 medications
T403	SectionSkip 8179 9748;9753 11689;11692 13629;13632 13652	PETCT Limited Whole Body Vertex to Mid Thigh 01/10/2018  COMPARISON (including at least the prior year or since last change in therapy):   08/18/2014    CLINICAL HISTORY:   71 years old Female with history of BRCA1 genetic carrier with a history of ovarian cancer and triple negative right breast IDC with new masses on mammogram 12/22/2017.    FINDINGS:  Lymph nodes: No hypermetabolic lymphadenopathy.  Lungs: No metastases.  Abdominal and pelvic organs: No metastases.  Bones: No metastases.  Other: Right lateral breast dumbbell shaped enhancing hypermetabolic mass measures 2.7 x 1.7 cm (SUV Max 10.5 for largest component).    Non-oncologic findings:  Brain:   Unremarkable, symmetric, FDG uptake is seen throughout the cortical gray matter, basal ganglia and the cerebellum.  No mass effect.  While these images appear within normal limits, MRI is recommended to rule out intracranial and/or skull base metastases if clinically indicated.  Neck:   Otherwise unremarkable.  Chest:   Unchanged right upper lobe pleural-based mass measuring 2.4 cm x 1.0 cm, dating back to 08/18/2014, without significant FDG avidity. Unchanged left upper and lower lobe pulmonary nodules measuring up to 6 mm in the left lower lobe (series 3, image 121 and image 32).  Abdomen/Pelvis:   Otherwise unremarkable.  Musculoskeletal:   Scattered bone islands in the pelvis are unchanged compared to 08/18/2014. Multilevel degenerative changes of the cervical and lumbar spine. Unchanged 3.4 cm lipomatous lesion in the right tensor fascia lata. Midline abdominal staples.    IMPRESSION: Hypermetabolic  (FDG avid) right lateral breast mass measures 2.7 x 1.7 cm compatible with recurrent disease. No evidence of hypermetabolic metastatic disease.     Right breast diagnostic mammography, Limited R breast US 12/22/2017  Comparison:  Prior examinations dated 10/11/2017, 10/11/2017, 10/04/2017 (MRI) and 01/23/2017 were reviewed for comparison.    Mammographic Findings:  There are scattered areas of fibroglandular density.  BB marker on the upper outer right breast indicating patient-palpated lump corresponds to two masses, both biopsy-proven IDC (ribbon clip and heart clip). The irregular mass containing the ribbon clip now measures approximately 14 mm, previously 11 mm, and the more posterior obscured mass containing the heart clip now measures approximately 15 mm, previously 9 mm.  BB marker on the lower central/slightly outer right breast indicates second patient-palpated lump, for which there is no mammographic correlate.  Ultrasound Findings:  There is no sonographic abnormality (no correlate) to patient-palpated lump in the lower central/slightly outer right breast, at approximately 7 o'clock, 4 cm from nipple.  Limited ultrasound of the right axilla demonstrates lymph nodes with normal cortical thickness and morphology.    IMPRESSION:   Right breast: Known biopsy proven malignancy (BI-RADS 6).    Recommendations:  1. Recommend continued surgical/oncologic management of two-site biopsy-proven right breast malignancy. Of note, right axillary lymph nodes appear sonographically normal at today's examination.    2. Recommend clinical follow up for patient-palpated lump in the lower central/slightly outer right breast, for which there is no mammographic nor sonographic correlate. If indicated, palpation-guided FNA could be pursued.    Bilateral MRI of Breasts 10/04/2017  Comparison:  Prior examinations dated 01/23/2017 (mammogram), 07/08/2016 and 11/10/2015 were reviewed for comparison.  MRI Findings:  This bilateral breast MRI exam demonstrates minimum background enhancement.  There are scattered areas of fibroglandular tissue.    RIGHT Breast:  There is a new 12 x 7 x 7 mm (ML x AP x CC) irregularly shaped mass with spiculated margins in the upper outer quadrant of the right breast. Signal intensity/time curve demonstrates rapid initial rise and washout enhancement kinetics.  This lesion is best seen on axial postcontrast image # 90 and sagittal reformation #341.  More posteriorly and laterally in the right breast, there is a second new 6 x 6 x 7 mm (ML x AP x CC) irregularly shaped mass with irregular margins. Signal intensity/time curve demonstrates rapid initial rise and washout enhancement kinetics.  This lesion is best seen on image # 90 and sagittal reformation #363.    LEFT Breast:  The previously described area of non-mass enhancement with linear distribution and clumped internal enhancement in the lower outer left breast is significantly less conspicuous than on MRI dated 07/08/2016, and can no longer be accurately measured. No new abnormal areas of enhancement or other MRI features of malignancy are identified.    IMPRESSION:   Right breast: Suspicious (BI-RADS 4).  Left breast: Benign (BI-RADS 2).    Recommendations:  1. Two new irregular masses demonstrating rapid enhancement with washout are noted in the upper outer quadrant of the right breast. Recommend diagnostic right breast mammogram with targeted ultrasound for further evaluation and biopsy planning, with possible stereotactic or ultrasound-guided biopsy to follow. If no correlate is identified by mammogram or ultrasound, then recommend MR-guided core biopsy.    2. Significant interval decrease in conspicuity of the previously described area of non-mass enhancement in the lower outer quadrant of the left breast, compatible with a benign etiology. Annual mammography in addition to MRI is recommended in patients undergoing high-risk screening.
A58	SectionSkipType T403 radiology_report
R27	BeginsOnOrAt Arg1:T394 Arg2:T397	
R29	HappensAtOnDuring Arg1:T379 Arg2:T378	
R30	HappensAtOnDuring Arg1:T363 Arg2:T362	
R31	HappensAtOnDuring Arg1:T348 Arg2:T347	
R32	HappensAtOnDuring Arg1:T165 Arg2:T390	
R33	HappensAtOnDuring Arg1:T385 Arg2:T388	
T396	Frequency 14060 14066	weekly
R28	Temporal Arg1:T394 Arg2:T396	
R34	TreatmentDesc Therapy:T394 Desc:T395	
T402	MaritalStatus 6626 6632	Single
T404	Tobacco 6761 6773	Never Smoker
A56	NegationModalityVal T404 negated
T405	Tobacco 6778 6807	Smokeless tobacco: Never Used
A59	NegationModalityVal T405 negated
T406	Alcohol 6812 6826	Alcohol use No
A60	NegationModalityVal T406 negated
T407	Drugs 6831 6843	Drug use: No
A61	NegationModalityVal T407 negated
T408	MaritalStatus 7003 7011	Divorced
T409	LivingCondition 7015 7027	Living alone
T410	SDoH 6950 6956	2 sons
T411	Age 4 15	71 year old
T412	ClinicalCondition 53 59	cancer
A63	ChronicVal T412 non-chronic
A64	ContinuityVal T412 new
T413	Site 73 79	breast
T414	Laterality 67 72	right
R35	LateralityOfSite Arg1:T414 Arg2:T413	
T415	Age 114 121	71 y.o.
R36	ResultOfTest Desc:T356 Test:T348	
R37	SiteOf Arg1:T361 Arg2:T359	
T416	Radiology 482 492	Ultrasound
A66	IntentVal T416 diagnosis
T417	Site 475 481	Breast
T418	Laterality 473 474	R
R40	SiteOf Arg1:T417 Arg2:T416	
R41	LateralityOfSite Arg1:T418 Arg2:T417	
T419	Datetime 462 472	10/04/2017
R42	HappensAtOnDuring Arg1:T419 Arg2:T416	
T420	Site 497 528	10 o'clock 7 cm from the nipple
T421	Size 531 549	0.7 x 0.9 x 0.9 cm
T422	RadPathResult 550 554	mass
A67	RadPathResultVal T422 InitialCancerDiagnosis
R43	TestOrProcedureReveals Test:T416 Desc:T421	
R44	NotUndergoneBecauseOf Arg1:T416 Reason:T422	
R45	SiteOf Arg1:T420 Arg2:T422	
T423	RadPathResult 558 562	mass
A68	RadPathResultVal T423 InitialCancerDiagnosis
T424	Site 579 611	10 o'clock 10 cm from the nipple
T425	Size 622 638	1 x 0.5 x 0.6 cm
A69	EpisodeDescription T425 FirstOccurrence
R46	ResultOfTest Desc:T423 Test:T416	
R47	SiteOf Arg1:T424 Arg2:T423	
R48	TestOrProcedureReveals Test:T416 Desc:T425	
T426	Site 824 855	10 o'clock 7 cm from the nipple
T427	Size 856 861	0.9cm
T428	Histology 865 868	IDC
A70	HistoryVal T428 new
A71	EpisodeDescription T428 FirstOccurrence
T429	Grade 884 885	3
A72	HistoryVal T429 new
A73	EpisodeDescription T429 FirstOccurrence
T430	BiomarkerName 886 888	ER
A74	HistoryVal T430 new
A75	EpisodeDescription T430 FirstOccurrence
T431	BiomarkerResult 889 897	negative
A76	EpisodeDescription T431 FirstOccurrence
A77	BiomarkerResultVal T431 Negative
R49	BiomarkerRel Arg1:T431 Arg2:T430	
T432	BiomarkerName 898 900	PR
A78	HistoryVal T432 new
A79	EpisodeDescription T432 FirstOccurrence
T433	BiomarkerResult 901 903	1%
A80	EpisodeDescription T433 FirstOccurrence
A81	BiomarkerResultVal T433 LowPositive
R50	BiomarkerRel Arg1:T432 Arg2:T433	
T434	BiomarkerName 904 908	Her2
A82	HistoryVal T434 new
A83	EpisodeDescription T434 FirstOccurrence
T435	BiomarkerResult 909 910	0
A84	EpisodeDescription T435 FirstOccurrence
A85	BiomarkerResultVal T435 Negative
R51	BiomarkerRel Arg1:T435 Arg2:T434	
T436	Pathology 910 918	IHC/FISH
A86	IntentVal T436 diagnosis
R52	TestOrProcedureReveals Test:T436 Desc:T434	
T437	BiomarkerResult 919 927	negative
A87	EpisodeDescription T437 FirstOccurrence
A88	BiomarkerResultVal T437 Negative
R53	BiomarkerRel Arg1:T437 Arg2:T434	
T438	Pathology 935 939	Ki67
T439	RadPathResult 943 949	30-40%
A89	NegationModalityVal T37 negated
R54	TestOrProcedureReveals Test:T379 Desc:T37	
T440	Symptom 1257 1262	fever
A90	NegationModalityVal T440 negated
A91	NegationModalityVal T39 negated
A92	NegationModalityVal T40 negated
A93	NegationModalityVal T41 negated
A94	NegationModalityVal T42 negated
A95	NegationModalityVal T43 negated
A96	NegationModalityVal T44 affirmed
A97	NegationModalityVal T45 negated
A98	NegationModalityVal T46 negated
A99	IsPresentOnFirstCancerDiagnosis T44 yes
A100	IsCausedByDiagnosedCancer T44 no
A101	ChronicVal T44 chronic
T441	Symptom 1407 1417	congestion
A102	NegationModalityVal T441 negated
A103	NegationModalityVal T48 negated
A104	NegationModalityVal T49 negated
A105	NegationModalityVal T50 negated
A106	NegationModalityVal T51 negated
A107	NegationModalityVal T52 negated
A108	NegationModalityVal T53 negated
A109	NegationModalityVal T54 negated
A110	NegationModalityVal T55 negated
A111	NegationModalityVal T56 negated
A112	NegationModalityVal T57 negated
A113	NegationModalityVal T58 negated
A114	NegationModalityVal T59 negated
A115	NegationModalityVal T60 negated
A116	NegationModalityVal T61 negated
A117	NegationModalityVal T62 negated
A118	NegationModalityVal T64 negated
A119	NegationModalityVal T65 negated
A120	NegationModalityVal T66 negated
A121	NegationModalityVal T67 negated
A122	NegationModalityVal T68 negated
A123	NegationModalityVal T69 negated
A124	NegationModalityVal T70 negated
A125	NegationModalityVal T71 negated
A126	NegationModalityVal T72 negated
A127	NegationModalityVal T73 negated
A128	NegationModalityVal T74 negated
A129	NegationModalityVal T75 negated
A130	NegationModalityVal T76 negated
A131	NegationModalityVal T77 negated
T442	Symptom 1953 1960;1963 1971	vaginal bleeding
A132	NegationModalityVal T442 negated
T443	Symptom 1975 1984	discharge
A133	NegationModalityVal T443 negated
A134	NegationModalityVal T80 negated
A135	NegationModalityVal T81 negated
A136	NegationModalityVal T82 negated
A137	NegationModalityVal T83 negated
A138	NegationModalityVal T85 negated
A139	NegationModalityVal T86 negated
T444	Site 2164 2170	Breast
A140	NegationModalityVal T87 affirmed
A141	ChronicVal T87 non-chronic
A142	ContinuityVal T87 stable
R55	SiteOf Arg1:T444 Arg2:T87	
T445	Site 2211 2217	axilla
R56	SiteOf Arg1:T445 Arg2:T87	
A143	NegationModalityVal T88 negated
A144	NegationModalityVal T89 negated
A145	NegationModalityVal T90 negated
A146	NegationModalityVal T91 negated
A147	NegationModalityVal T92 negated
A148	NegationModalityVal T93 negated
A149	NegationModalityVal T94 negated
A150	NegationModalityVal T95 negated
A151	NegationModalityVal T96 negated
A152	NegationModalityVal T97 negated
A153	NegationModalityVal T98 negated
A154	NegationModalityVal T99 negated
A155	NegationModalityVal T100 negated
A156	NegationModalityVal T101 negated
A157	NegationModalityVal T102 negated
A158	NegationModalityVal T103 affirmed
A159	IsPresentOnFirstCancerDiagnosis T103 no
A160	ChronicVal T103 non-chronic
A161	ContinuityVal T103 stable
A162	ChronicVal T157 chronic
A163	ContinuityVal T157 stable
T446	DiagnosticLabTest 5429 5435	CA-125
T447	LabTestResult 5420 5428	Elevated
A164	LabTestResultVal T447 abnormal
R57	ResultOfTest Desc:T447 Test:T446	
T448	ClinicalCondition 5441 5479	GERD (gastroesophageal reflux disease)
A165	ChronicVal T448 chronic
A166	ContinuityVal T448 stable
T449	ClinicalCondition 5485 5498	Kidney stones
A167	ChronicVal T449 chronic
A168	ContinuityVal T449 stable
T450	ClinicalCondition 5515 5534	papillary carcinoma
A169	ChronicVal T450 chronic
A170	ContinuityVal T450 stable
T451	Metastasis 5504 5514	Metastatic
A171	HistoryVal T451 history
R58	TumorDesc TumorDetails:T450 Desc:T451	
T452	Site 5538 5548	lymph node
R59	SiteOf Arg1:T452 Arg2:T451	
T453	Site 5568 5586	pelvic lymph nodes
T454	Laterality 5563 5567	left
R60	LateralityOfSite Arg1:T454 Arg2:T453	
R61	SiteOf Arg1:T453 Arg2:T451	
T455	ClinicalCondition 5591 5632	NSVD (normal spontaneous vaginal delivery
A172	ChronicVal T455 non-chronic
A173	ContinuityVal T455 stopped
T456	TumorCharacteristics 5696 5722	platinum-sensitive disease
T457	ClinicalCondition 5780 5786	Cancer
A174	ExperiencerVal T457 family
T458	Age 5794 5796	35
T459	ClinicalCondition 5801 5814	breast cancer
A176	ExperiencerVal T459 family
T460	ClinicalCondition 5819 5831	Hypertension
A177	ExperiencerVal T460 family
T461	ClinicalCondition 5844 5850	Stroke
A178	ExperiencerVal T461 family
T462	Age 5858 5860	88
T463	ClinicalCondition 5867 5875	Diabetes
A180	ExperiencerVal T463 family
T464	ClinicalCondition 5906 5918	liver cancer
A181	ExperiencerVal T464 family
T465	ClinicalCondition 5923 5931	Diabetes
A182	ExperiencerVal T465 family
T466	ClinicalCondition 5945 5957	Hypertension
A183	ExperiencerVal T466 family
T467	ClinicalCondition 5971 5979	Glaucoma
A184	ExperiencerVal T467 family
T468	ClinicalCondition 5993 6005	Hypertension
A185	ExperiencerVal T468 family
T469	ClinicalCondition 6018 6026	Diabetes
A186	ExperiencerVal T469 family
T470	ClinicalCondition 6039 6047	Glaucoma
A187	ExperiencerVal T470 family
T471	ClinicalCondition 6081 6094	Breast cancer
A188	ExperiencerVal T471 family
T472	Age 6074 6076	62
T473	ClinicalCondition 6121 6130	Amblyopia
A190	NegationModalityVal T473 negated
A191	ExperiencerVal T473 family
T474	ClinicalCondition 6143 6152	Blindness
A192	NegationModalityVal T474 negated
A193	ExperiencerVal T474 family
T475	ClinicalCondition 6165 6174	Cataracts
A194	NegationModalityVal T475 negated
A195	ExperiencerVal T475 family
T476	ClinicalCondition 6187 6198	Keratoconus
A196	NegationModalityVal T476 negated
A197	ExperiencerVal T476 family
T477	ClinicalCondition 6211 6224	Macular degen
A198	NegationModalityVal T477 negated
A199	ExperiencerVal T477 family
T478	ClinicalCondition 6237 6255	Retinal detachment
A200	NegationModalityVal T478 negated
A201	ExperiencerVal T478 family
T479	ClinicalCondition 6268 6278	Strabismus
A202	NegationModalityVal T479 negated
A203	ExperiencerVal T479 family
T480	ClinicalCondition 6291 6306	Anesth problems
A204	NegationModalityVal T480 negated
A205	ExperiencerVal T480 family
A206	NegationModalityVal T191 negated
A207	ExperiencerVal T191 family
A208	NegationModalityVal T192 negated
A209	ExperiencerVal T192 family
A210	NegationModalityVal T193 negated
A211	ExperiencerVal T193 family
A212	NegationModalityVal T194 negated
A213	ExperiencerVal T194 family
A214	NegationModalityVal T195 negated
A215	ExperiencerVal T195 family
A216	NegationModalityVal T196 negated
A217	ExperiencerVal T196 family
A218	NegationModalityVal T197 negated
A219	ExperiencerVal T197 family
A220	NegationModalityVal T198 negated
A221	ExperiencerVal T198 family
A222	NegationModalityVal T199 negated
A223	ExperiencerVal T199 family
T481	Age 6957 6959	51
T482	Age 6961 6963	46
T483	Age 13702 13708	71 y.o
T484	ClinicalCondition 13724 13737	breast cancer
A227	ChronicVal T484 non-chronic
A228	ContinuityVal T484 worsening
A229	ExperiencerVal T484 patient
T485	Laterality 13722 13723	R
A230	ChronicVal T329 non-chronic
A231	ContinuityVal T329 worsening
T486	Radiology 13813 13818	PETCT
A232	IntentVal T486 TreatmentAssessment
T487	RadPathResult 13832 13838	growth
A233	RadPathResultVal T487 Progression
R62	ResultOfTest Desc:T487 Test:T486	
T488	Size 13863 13888	1.2 x 0.7 to 2.7 x 1.7 cm
A234	ExperiencerVal T488 patient
A235	HistoryVal T488 new
A236	EpisodeDescription T488 Progression
R63	TestOrProcedureReveals Test:T486 Desc:T488	
T489	Site 13844 13850	breast
T490	Laterality 13842 13843	R
R64	LateralityOfSite Arg1:T490 Arg2:T489	
T491	TumorCharacteristics 13851 13857	lesion
R65	SiteOf Arg1:T489 Arg2:T491	
R66	TestOrProcedureReveals Test:T486 Desc:T491	
R67	SiteOf Arg1:T413 Arg2:T412	
R13	SiteOf Arg1:T361 Arg2:T360	
T492	TreatmentType 14078 14083	chemo
R38	BeginsOnOrAt Arg1:T492 Arg2:T397	
R68	ResultOfTest Desc:T439 Test:T438	
R69	TestOrProcedureReveals Test:T400 Desc:T429	
R70	TestOrProcedureReveals Test:T400 Desc:T430	
R71	TestOrProcedureReveals Test:T400 Desc:T432	
R72	TestOrProcedureReveals Test:T400 Desc:T434	
R73	TestOrProcedureReveals Test:T400 Desc:T427	
R74	TestOrProcedureReveals Test:T363 Desc:T369	
R75	TestOrProcedureReveals Test:T363 Desc:T371	
R76	BiomarkerRel Arg1:T371 Arg2:T372	
R77	TestOrProcedureReveals Test:T373 Desc:T371	
R78	TestOrProcedureReveals Test:T363 Desc:T375	
R79	SiteOf Arg1:T426 Arg2:T400	
R80	TestOrProcedureReveals Test:T379 Desc:T383	
A49	RadPathResultVal T380 Progression
T493	Site 1076 1086	Whole Body
R81	SiteOf Arg1:T493 Arg2:T379	
A237	IntentVal T438 diagnosis
A238	RadPathResultVal T439 Others
R14	ResultOfTest Desc:T360 Test:T348	
R39	TestOrProcedureReveals Test:T348 Desc:T359	
A239	DiseaseStateVal T391 progression-recurrence
A240	DiseaseStateVal T36 progression-recurrence
R82	SizeOf Arg1:T351 Arg2:T352	
R83	SizeOf Arg1:T358 Arg2:T356	
R84	SizeOf Arg1:T359 Arg2:T360	
R85	SizeOf Arg1:T421 Arg2:T422	
R86	SizeOf Arg1:T425 Arg2:T423	
R87	SizeOf Arg1:T365 Arg2:T375	
R88	SizeOf Arg1:T427 Arg2:T428	
R89	SizeOf Arg1:T383 Arg2:T380	
R90	SizeOf Arg1:T488 Arg2:T491	
T494	PatientCharacteristics 6973 6987	2 miscarriages
T495	PatientCharacteristics 6989 6999	2 abortion
T496	hpi_start 0 2	ID
T497	hpi_end 1212 1219	disease
T498	ap_start 13660 13670	ASSESSMENT
T499	ap_end 14200 14203	12.
A241	NegationModalityVal T492 hypothetical_in_future
T500	Cycles 14184 14185	1
T501	Cycles 14187 14188	2
T502	Cycles 14190 14191	5
T503	Cycles 14193 14194	8
T504	Cycles 14200 14202	12
